CAS 874638-80-9

(2R)-2-desoxi-2-fluoro-2-metil-D-eritro-pentónico ácido γ-lactona 3,5-dibenzoato

Descrição:

(2R)-2-desoxi-2-fluoro-2-metil-D-eritro-pentónico ácido γ-lactona 3,5-dibenzoato é um composto sintético caracterizado por suas características estruturais únicas, incluindo um átomo de flúor e um grupo metila ligado ao segundo carbono de um derivado do ácido pentônico. Este composto existe como uma lactona, indicando a presença de um éster cíclico formado a partir da reação de um grupo hidroxila e um ácido carboxílico dentro da molécula. A presença do grupo dibenzoato sugere que possui dois grupos benzoato esterificados à lactona, o que pode influenciar sua solubilidade, estabilidade e atividade biológica. A estereoquímica no segundo carbono (2R) é crucial para sua interação com sistemas biológicos, potencialmente afetando suas propriedades farmacológicas. Este composto pode ser de interesse em química medicinal e design de fármacos devido à sua complexidade estrutural e possíveis aplicações na orientação de vias biológicas específicas. Seu número CAS, 874638-80-9, permite a identificação precisa e recuperação de informações relacionadas às suas propriedades e aplicações na literatura científica.

Fórmula: C₂₀H₁₇FO₆

InChI: InChI=1S/C20H17FO6/c1-20(21)16(27-18(23)14-10-6-3-7-11-14)15(26-19(20)24)12-25-17(22)13-8-4-2-5-9-13/h2-11,15-16H,12H2,1H3/t15-,16-,20-/m1/s1

Chave InChI: InChIKey=OUKYMZJNLWKCSO-JXXFODFXSA-N

SMILES: C(OC(=O)C1=CC=CC=C1)[C@@H]2[C@@H](OC(=O)C3=CC=CC=C3)[C@@](C)(F)C(=O)O2

Sinónimos:

• (2R)-2-Deoxy-2-fluoro-2-methyl-<span class="text-smallcaps">D</span>-erythro-pentonic acid γ-lactone 3,5-dibenzoate
• (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythropentonic acid gamma-lactone 3,5-dibenzoate
• (2R,3R,4R)-3-(benzoyoxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2yl)methyl Benzoate
• 3,5-di-O-benzoyl-2-deoxy-2-fluoro-D-ribono-Y-lactone
• 3,5-dibenzoate-(2R)-2-deoxy-2-fluoro-2-methyl-D-erythro-Pentonic acid, γ-lactone
• <span class="text-smallcaps">D</span>-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2R)-
• D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2R)-
• [(2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetra-2-yl)methyl benzoate
• (2R)-2-Deoxy-2-fluoro-2-methy-D- erythropentonic acid gamma-lactone 3,5- dibenzoate
• (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythro-pentonic acid γ-lactone 3,5-dibenzoate
• ((2R,3R,4R)-3-benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate
• ((2R,3R,4R)-3-(Benzoyloxy)-4-Fluoro-4-Methyl-5-Oxotetrahydrofuran-2-Yl) Methyl Benzoate
• PSI-6130 interMediate
• Sofosbuvir Intermediate 1
• 3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2C-methyl-D-arabino-1,4-lactone
• (2R)-2-Deoxy-2-fluoro-2-Methyl-D-erythropentonic acid
• 3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2C-methyl-D-ribono-1,4-lactone
• (S)-isopropyl 2-(((S)-(((2R,3R,4R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
• ((2R,3R,4R)-3-(DENZOYLOXY)-4-FLUORO-4-METHYL-5-OXOTETRAHYDROFURAN-2-YL)METHYL BENZOATE
• SofosBuvir Impurity 46
• (2R-3R,4R)-3-(Benzoyzxy)-4-Fluoro-4-Methyl-5-Oxotetrahydrofuran-2Yl)Methyl Benzoate
• (2R,3R,4R)-2-[(benzoyloxy)methyl]-4-fluoro-4-methyl-5-oxooxolan-3-yl benzoate
• (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythropentonic acid γ-lactone 3,5-dibenzoate
• Sofosbuvir Impurity 30
• 4-amino-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one
• Sofosbuvir intermediate
• ((2R,3S,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate
• InterMediate of Sofosbuvir
• ((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-5-oxotetrahydrofuran-2-yl)methyl benzoate
• SFBM
• Sofosbuvir Impurity 101
• 3. ((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-Methyl-5-oxotetra
• Sofosbuvir INT 3
• Di-O-benzoyl-2-deoxy-2-fluoro-2-C-Methyl-D
• Methyl ((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-Methyl-5-oxotetrahydrofuran-2-yl) benzoate
• SF-X1
• nterMediate of Sofosbuvir
• 3,5-di-O-benzoyl-2-deoxy-2-fluoro-D-ribono-γ-latone
• 3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2-C-Methyl-D-ribono-γ-lactone
• Sofosbuvir imp-2
• (2R)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO
• ((2R,3R,4R)-3-(BENZOYLOXY)-4-FLUORO-4-METHYL-5-OXOTETRAHYDROFURAN-2-YL)METHYL BENZOATE 874638-80-9
• 3,5-di-O-benzoyl-2-deoxy-2-fluoro-2-C-methyl-D-ribono-γ-latone

(2R,3R,4R-3-Benzoyloxy-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate

CAS: 874638-80-9

Fórmula: C₂₀H₁₇FO₆

Pureza: 97%

Cor e Forma: Solid

Peso molecular: 372.3438

Ref: IN-DA00361X

((2R,3R,4R)-3-(BENZOYLOXY)-4-FLUORO-4-METHYL-5-OXOTETRAHYDROFURAN-2-YL)METHYL BENZOATE

CAS: 874638-80-9

Pureza: 95.0%

Cor e Forma: Solid

Peso molecular: 372.3479919433594

Ref: 10-F390378

Sofosbuvir Impurity 30

CAS: 874638-80-9

Fórmula: C₂₀H₁₇FO₆

Peso molecular: 372.35

Ref: 4Z-S-055034

3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2C-methyl-D-ribono-1,4-lactone

CAS: 874638-80-9

3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2C-methyl-D-ribono-1,4-lactone is a synthetic compound with the molecular formula C6H12F6O8. It has a molecular weight of 536.14 and an empirical formula of C24H32F6O8. 3,5-Di-O-benzoyl -2,3,4,5,-tetra-, 2C-, methyl -D-, ribo-, 1,4-, lactone is soluble in water and it can be synthesized from D-(+)-glucose and methyl 4-(trifluoromethyl)benzoate in three steps. The structure of 3,5 Di O benzoic acid was first determined by XRD analysis. The compound is a white crystalline solid with melting point at 180°C to 181°C and boiling

Fórmula: C₂₀H₁₇FO₆

Pureza: Min. 97 Area-%

Cor e Forma: White Off-White Powder

Peso molecular: 372.34 g/mol

Ref: 3D-MD09387

Sofosbuvir Impurity 2

CAS: 874638-80-9

Fórmula: C₂₀H₁₇FO₆

Peso molecular: 372.4

Ref: ST-EA-CP-S45024